Cyclo Therapeutics, Inc. Financial Report - Key Insights for August 1, 2023

Based on the provided section of the financial report, here are the key insights extracted:

1. Entity Information:

• Company Name: Cyclo Therapeutics, Inc.
• CIK Number: 0000922247
• SEC Registration: 000-25466
• EIN: 59-3029743
• Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
• Phone Number: 386-418-8060

2. Stock Information:

• Common Stock Symbol: CYTH
• Market: NASDAQ
• Warrants Symbol: CYTHW
• Warrants to Purchase Common Stock: Specific mention of a class of warrants available.

3. Reporting Period:

• Date of Report: August 1, 2023
• Reporting Context: The report is focused on a specific day (August 1, 2023), indicating it may relate to a particular event or transaction on that date.

4. Stock Classifications:

• The report includes classifications for both Common Stock and Warrants to Purchase Common Stock, suggesting there may be significant activities or disclosures related to these securities.

5. XBRL Instance:

• The document is structured in XBRL (eXtensible Business Reporting Language), indicating that it is intended for digital reporting, facilitating analysis and comparison.

6. Regulatory Compliance:

• The report appears to comply with SEC regulations, as indicated by the use of specific identifiers and references to commonly used financial reporting standards (US GAAP).

Overall, the report provides essential information regarding the company's securities and regulatory filings, with a focus on its common stock and associated warrants. The reporting date suggests that the details may be pertinent to recent financial activities or announcements related to Cyclo Therapeutics, Inc.